126 related articles for article (PubMed ID: 6329114)
1. Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonist.
Yamada K; Shuto K; Kubo K; Nakamizo N
Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):141-54. PubMed ID: 6329114
[TBL] [Abstract][Full Text] [Related]
2. KF4939, a new anti-platelet agent, inhibits activation of phospholipase C and A2 in rabbit platelets.
Yamada K; Kumada Y; Kubo K
Jpn J Pharmacol; 1985 Sep; 39(1):108-11. PubMed ID: 3934441
[TBL] [Abstract][Full Text] [Related]
3. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
Brammer JP; Maguire MH
Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of platelet aggregation by a new agent, 2,2'-dithiobis-(N-2-hydroxypropyl benzamide) (KF4939).
Yamada K; Shuto K; Nakamizo N
Thromb Res; 1983 Jan; 29(2):197-206. PubMed ID: 6405499
[TBL] [Abstract][Full Text] [Related]
5. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
Busse WD; Seuter F
Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin-independent inhibition of platelet phospholipase A2 by calmodulin antagonists.
Watanabe T; Hashimoto Y; Teramoto T; Kume S; Naito C; Oka H
Arch Biochem Biophys; 1986 May; 246(2):699-709. PubMed ID: 3085592
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
8. Studies on the antiplatelet effect of the stable epoprostenol analogue beraprost sodium and its mechanism of action in rats.
Umetsu T; Murata T; Nishio S
Arzneimittelforschung; 1989 Jan; 39(1):68-73. PubMed ID: 2541730
[TBL] [Abstract][Full Text] [Related]
9. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
10. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
Han P; Boatwright C; Ardlie NG
Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
[TBL] [Abstract][Full Text] [Related]
11. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
[TBL] [Abstract][Full Text] [Related]
12. 14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
Bernstrom K; Malcolm K; McGee J; Maclouf J; Levy-Toledano S; Falck JR; Fitzpatrick FA
Mol Pharmacol; 1991 Feb; 39(2):114-9. PubMed ID: 1847490
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
Yamada K; Kubo K; Shuto K; Nakamizo N
Jpn J Pharmacol; 1984 Nov; 36(3):283-90. PubMed ID: 6521073
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine inhibits stimulated platelets at the arachidonic acid pathway.
Nosál R; Jancinová V; Petríková M
Thromb Res; 1995 Mar; 77(6):531-42. PubMed ID: 7624839
[TBL] [Abstract][Full Text] [Related]
15. [Inhibiting action of anti-arrhythmia agents of the phenothiazine series--etmozin and its diethylamino analog--on platelet aggregation and metabolism of endogenous arachidonic acid].
Mazurov AV; Leĭtin VL; Repin VS; Rozenshtraukh LV; Smirnov VN
Biull Eksp Biol Med; 1984 Jan; 97(1):63-5. PubMed ID: 6419795
[TBL] [Abstract][Full Text] [Related]
16. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
[TBL] [Abstract][Full Text] [Related]
17. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
18. Involvement of disulfide-sulfhydryl interaction in anti-platelet actions of KF4939.
Yamada K; Kubo K; Shuto K; Nakamizo N
Thromb Res; 1985 Apr; 38(1):61-9. PubMed ID: 4002199
[TBL] [Abstract][Full Text] [Related]
19. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
20. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
